Non-protein Clostridial toxin compositions
US12171816B2 · kind B2 · utility
0Cited by
259References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2023 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Apr 18, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions that stabilize a Clostridial toxin active ingredient are described. The compositions can be liquid or solid compositions, and comprise a surfactant and an antioxidant. In some embodiments, the compositions comprise a surfactant selected from a poloxamer and a polysorbate; an antioxidant selected from methionine, N-acetyl cysteine, ethylenediaminetetraacetic acid and combinations thereof, and, optionally, a tonicity agent and/or a lyoprotector selected from, for example, trehalose, sucrose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.